The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer.
about
Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor RadiosensitizationHeat shock protein 90 targeting therapy: state of the art and future perspectiveHsp90: A New Player in DNA Repair?UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib.Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer.Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer.HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models.The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus.Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cellsThe HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells.Ganetespib radiosensitization for liver cancer therapyA novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer.Re-examining HSPC1 inhibitors.Characterization of titanium dioxide nanoparticles modified with polyacrylic acid and H2O2 for use as a novel radiosensitizer.Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.dbCRSR: a manually curated database for regulation of cancer radiosensitivity.
P2860
Q26771165-5FD5D1AE-F317-4706-AFE2-408F0F617A08Q26776302-C802C7FD-2B04-4CB4-907E-30AA32004C2EQ26778944-5F4FBC14-744E-43E8-85E5-67929D0DC6E7Q27853065-7C4B7BFF-23A7-43EA-BEFD-721EB5C23BBCQ30276399-46F9C06C-4437-4332-A0AF-74715118E982Q33848888-B047E8F0-5633-4EC4-A8F1-DB1CE0A3CED5Q34793260-89CF3E1D-F03A-473B-93E6-C262B753FA80Q35606420-72000A38-7C40-4272-8BD9-58CB4F687554Q35761391-DD7C0BA2-2353-4BC8-B7E3-1E14D97686A1Q35818450-B6486262-4D12-4473-A41D-623FE65FE936Q37013260-5626B5A3-8E13-4AA1-AC92-E05BBFAF5B98Q37536525-F4221101-1149-472F-A086-F2397CBBF5A3Q38931732-A69C2DF5-5641-49B9-A012-8735ED871B9FQ46471584-33E33CDF-70BD-4C4B-BE35-F963FA7FAD01Q48210380-A90FE75E-A802-49A4-B95F-6F955B440B1DQ48292976-129011E0-B8ED-4C97-A679-151B786BA865Q55402075-457C57FE-B729-4570-83D3-8B4125E363CB
P2860
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The HSP90 inhibitor ganetespib ...... activity in colorectal cancer.
@ast
The HSP90 inhibitor ganetespib ...... activity in colorectal cancer.
@en
type
label
The HSP90 inhibitor ganetespib ...... activity in colorectal cancer.
@ast
The HSP90 inhibitor ganetespib ...... activity in colorectal cancer.
@en
prefLabel
The HSP90 inhibitor ganetespib ...... activity in colorectal cancer.
@ast
The HSP90 inhibitor ganetespib ...... activity in colorectal cancer.
@en
P2093
P2860
P1476
The HSP90 inhibitor ganetespib ...... activity in colorectal cancer.
@en
P2093
David A Proia
Donald L Smith
Manuel Sequeira
Richard C Bates
P2860
P2888
P304
P356
10.1007/S10637-014-0095-4
P577
2014-04-01T00:00:00Z
P5875
P6179
1047953350